A major study reports that weight-loss injections could lower the risk of developing breast cancer by nearly a third. The reporting says the potential benefit may extend beyond average-risk groups, including people considered at higher risk of the disease. While the coverage emphasizes a sizeable reduction in risk, it does not provide additional details in the supplied text on the study’s size, duration, or the specific medication used, nor does it describe how risk was measured or adjusted for other factors. The article frames the findings as landmark, indicating the study’s results could be relevant for future discussions about weight management and cancer prevention. However, based on the information provided here, the exact magnitude of risk reduction, eligibility criteria, and whether the findings apply to all breast cancer types are not specified. Overall, the sources agree that the study finds an association between the use of weight-loss injections and a reduced likelihood of breast cancer, including among higher-risk individuals, but they offer limited methodological detail in the excerpts.